南京科佰生物科技有限公司官方网站欢迎您的光临!
免费咨询热线: 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
HCC1599(人乳腺原发性导管癌)
CBP60415 | |
I. General information | |
Synonyms: | HCC1599 |
Background: | The HCC1599 breast cancer cell line was initiated on March 28, 1995, and took 10 months to establish. |
Species: | Homo sapiens, human |
Tissue: | mammary gland; breast/duct |
Disease: | TNM stage IIIA, grade 3, primary ductal carcinoma |
Gender: | female,44 years adult, Caucasian, White |
Morphology: | epithelial |
Growth Mode: | suspension, multicell aggregates |
Doubling Time: | N/A |
DNA Profile: | Amelogenin: X CSF1PO: 12 D13S317: 11 D16S539: 12,13 D5S818: 12 D7S820: 10,11 THO1: 9.3 TPOX: 8 vWA: 17 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI1640+20%FBS HCC1599完全培养基,# CBP60415M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | N/A |
Receptor Expression: | estrogen receptor, negative progesterone receptor, negative |
Oncogene: | her2/neu -, p53 - |
Genes Expressed: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
Cellular Products: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
Tumor Formation: | N/A |
Comments: | The tumor was classified as a TNM stage IIIA, grade 3, invasive ductal carcinoma. Information regarding lymph node metastasis is not available. The cells are poorly differentiated. The cells are negative for expression of Her2-neu and for expression of p53. The cells are negative for expression of estrogen receptor (ER) and for expression of progesterone receptor (PR). HCC1599 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 (EGP2), and for cytokeratin 19. An EBV-transformed lymphoblastoid cell line (HCC1599 BL) from the same patient is available as ATCC CRL-2332. For more information, please contact Cobioer (4008-750-250). |
扫一扫,关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号